Clinical trials
Active, not recruiting Hyperlipoproteinemia Type II trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CHU de Quebec-Universite Laval | 1 |
| Hospital do Coracao | 1 |
| Innovent Biologics (Suzhou) Co. Ltd. | 1 |
| National Medical Research Center for Therapy and Preventive Medicine | 1 |
| Novartis Pharmaceuticals | 1 |
| Oslo University Hospital | 1 |
| Region Örebro County | 1 |
| University Hospital, Linkoeping | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipoproteinemia Type II | 8 |
| Hypercholesterolemia | 2 |
| Cardiovascular Diseases | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hyperlipoproteinemia Type III | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms | 1 |
| Pancreatic Neoplasms | 1 |
Trials
Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.